Back
SpringWorks Therapeutics Stock Price Chart
Buy these stocks BEFORE President Trump returns to the Oval Office
See details on which stocks are poised to surge.
Buy
64
SWTX
SpringWorks Therapeutics
Last Price:
35.55
Seasonality Move:
54.9%
7 Day Trial
ALL ACCESS PASS
$
7
Trump wins! Dow to 75,000? Details here
See the explosive "Document 20" details here.- Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and SWTX is experiencing buying pressure, which is a positive indicator for future bullish movement.
SpringWorks Therapeutics Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 33.69 | Buy |
| 20-day SMA: | 31.5 | Buy |
| 50-day SMA: | 32.93 | Buy |
| 200-day SMA: | 40.28 | Sell |
| 8-day EMA: | 33.82 | Buy |
| 20-day EMA: | 32.54 | Buy |
| 50-day EMA: | 33.19 | Buy |
| 200-day EMA: | 36.27 | Buy |
SpringWorks Therapeutics Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.68 | Buy |
| Relative Strength Index (14 RSI): | 72.15 | Buy |
| Chaikin Money Flow: | 1709057 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (29.39 - 33.17) | Buy |
| Bollinger Bands (100): | (31.79 - 39.13) | Buy |
SpringWorks Therapeutics Technical Analysis
| Nov 1 | Nov 4 | Nov 5 | Nov 6 | Nov 7 | Nov 8 | Nov 11 | Nov 12 | Nov 13 | Nov 14 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov | ||||||||||
| 01 | 04 | 05 | 06 | 07 | 08 | 11 | 12 | 13 | 14 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for SpringWorks Therapeutics Stock
Is SpringWorks Therapeutics Stock a Buy?
- SpringWorks Therapeutics share price is 36.55 while SWTX 8-day simple moving average is 33.69, which is a Buy signal.
- The stock price of SWTX is 36.55 while SpringWorks Therapeutics 20-day SMA is 31.50, which makes it a Buy.
- SpringWorks Therapeutics 50-day simple moving average is 32.93 while SWTX share price is 36.55, making it a Buy technically.
- SWTX stock price is 36.55 and SpringWorks Therapeutics 200-day simple moving average is 40.28, creating a Sell signal.
SWTX Technical Analysis vs Fundamental Analysis
Buy
64
SpringWorks Therapeutics (SWTX)
is a Buy
Is SpringWorks Therapeutics a Buy or a Sell?
-
SpringWorks Therapeutics stock is rated a Buy
The current SpringWorks Therapeutics [SWTX] share price is $36.55. The Score for SWTX is 64, which is 28% above its historic median score of 50, and infers lower risk than normal.
SpringWorks Therapeutics Stock Info
Market Cap:
2.71B
Price in USD:
36.55
Share Volume:
2.08M
SpringWorks Therapeutics 52-Week Range
52-Week High:
53.92
52-Week Low:
19.61
Buy
64
SpringWorks Therapeutics (SWTX)
is a Buy
SpringWorks Therapeutics Share Price Forecast
-
What is the SpringWorks Therapeutics stock price today?
The SpringWorks Therapeutics stock price is 36.55 USD today. -
Will SWTX stock go up or go down?
SpringWorks Therapeutics> share price is forecast to RISE/FALL based on technical indicators -
Is SpringWorks Therapeutics overvalued?
According to simple moving average, exponential moving average, oscillators, and other technical indicators, SpringWorks Therapeutics is not overvalued.
Is SpringWorks Therapeutics Stock a Buy?
- SpringWorks Therapeutics share price is 36.55 while SWTX 8-day exponential moving average is 33.82, which is a Buy signal.
- The stock price of SWTX is 36.55 while SpringWorks Therapeutics 20-day EMA is 32.54, which makes it a Buy.
- SpringWorks Therapeutics 50-day exponential moving average is 33.19 while SWTX share price is 36.55, making it a Buy technically.
- SWTX stock price is 36.55 and SpringWorks Therapeutics 200-day simple moving average is 36.27, creating a Buy signal.
Fundamental Analysis of SpringWorks Therapeutics
Is SpringWorks Therapeutics a good investment?
- Analysts estimate an earnings increase this quarter of $0.55 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.41 per share, and an increase next year of $1.42 per share.
Technical Analysis of SpringWorks Therapeutics
Should I short SpringWorks Therapeutics stock?
- SWTX Moving Average Covergence Divergence (MACD) indicator is 0.68, suggesting SpringWorks Therapeutics is a Buy
- SpringWorks Therapeutics Relative Strength Index (RSI) is 72.15, which suggest SpringWorks Therapeutics is overbought
- The Bollinger Bands (25) for SpringWorks Therapeutics is (29.39 - 33.17), which suggest SpringWorks Therapeutics is a Buy
- The Bollinger Bands (100) for SpringWorks Therapeutics is (31.79 - 39.13), which suggest SpringWorks Therapeutics is a Buy
* SpringWorks Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.